- The share
- Arjo B
- 15 sty 2021 17:29
- 6,67 EUR (-2,66%)
Arjo interim report January-september 2020
”We add a very strong quarter to the books. We continue to deliver profitable growth and grow organically by 5.8% in the quarter, while increasing our operating profit by 67%,” says Joacim Lindoff, President and CEO. “The challenges associated with Covid-19 continues and we are handling the situation here and now while investing in our long-term agenda. We enter the fourth quarter with a good momentum and look forward to finish the year on a positive note,” adds Joacim Lindoff.
July-september 2020 in brief
- Net sales amounted to SEK 2,143 M (2,154).
Net sales grew organically by 5.8%.
- Adjusted EBITDA increased by 17.6% to SEK 448 M (381).
- Adjusted operating profit increased by 67.1% to SEK 208 M (125).
- Profit after financial items increased to SEK 176 M (60).
- Earnings per share increased to SEK 0.49 (0.16).
- Cash flow from operations increased to SEK 525 M (379).
- Cash conversion increased to 117.1% (109.5).
- After the end of the quarter: Acquisition of equity stake in US company Bruin Biometrics (BBI).
Fund managers, analysts and the media are invited to a teleconference on October 28 at 08.00 CET. Please see details below to join the conference:
Sweden: +46 8 519 993 83
USA: +1 833 526 8383
UK: +44 333 300 9266
A presentation will be held during the telephone conference. To access the presentation, please use this link: https://tv.streamfabriken.com/arjo-q3-2020
Alternatively, use the following link to download the presentation:
A recording of the teleconference will be available for 90 days via the following link: https://tv.streamfabriken.com/arjo-q3-2020
For more information, please contact:
Executive Vice President, Marketing Communications & Public Relations
Tel: +46 (0)10 335 4810
Investor Relations & Corporate Communications
Tel: +46 (0)10 335 4866
This information is information that Arjo AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at 07:00 CET on October 28, 2020.
At Arjo, we are committed to improving the everyday lives of people affected by reduced mobility and age-related health challenges. With products and solutions that ensure ergonomic patient handling, personal hygiene, disinfection, diagnostics, and the effective prevention of pressure ulcers and venous thromboembolism, we help professionals across care environments to continually raise the standard of safe and dignified care. Arjo has approximately 6,000 employees worldwide and customers in over 100 countries. In 2019, Arjo sales amounted to approximately SEK 8.9 billion. Arjo is listed on Nasdaq Stockholm and its head office is located in Malmö, Sweden. Everything we do, we do with people in mind. www.arjo.com